<h3>
    Mission</h3>

<p>
    To further the Strategic Plan by meeting the needs of underrepresented members of AGA, to include the spectrum of diversity
    as defined by race, gender, culture, ethnicity, religion or sexual preference. The specific intent of the committee is:
</p>

<ol>
    <li>
        To foster and promote involvement, advancement and recognition of underrepresented diverse constituents; and
    </li>

    <li>
        Through policy recommendations and programs,&nbsp; assist AGA members&rsquo; ability to address barriers to access and utilization
        of healthcare services among diverse patient populations, with attention to linguistic, racial, cultural, religious,
        sexual preference, age and economic&nbsp;diversity; &nbsp;and
    </li>

    <li>
        To convene two meetings annually to solicit comments, ideas and proposals from the constituency for further consideration
        by the committee.
    </li>
</ol>


<h3>Special Qualifications, Committee Chair</h3>

<ul>
    <li>Serves as an advocate on relevant issues.</li>
    <li>Advises the govering board on relevant issues where committee involvement is not feasible.</li>
</ul>


<h3>Committee Structure</h3>

<p>The committee consists of eight members (including a chair), plus a trainee, and are to be selected for their interest in
    issues that affect underrepresented minorities. Four members shall be appointed at-large and three members shall be appointed
    from among members of AGA and AGA Institute committees and the AGA Institute Council. A governing board member (who shall
    not count against the maximum membership) shall serve as a liaison to the committee and shall attend all committee meetings;
    additional members of the governing board (who shall not count against the maximum membership) may be assigned as team
    members to the committee but are not intended to attend any committee meetings. A chair-elect (who shall not count against
    the maximum membership) shall be appointed one year before the end of the term of the chair.</p>


<h3>Committee Functions</h3>

<ul>
    <li>Develop policy and programmatic recommendations to achieve the Committee&rsquo;s missions.</li>
    <li>Assess the Strategic Plan to ensure that the AGA&rsquo;s strategic directions reflect the interests and concerns of our
        diverse members; review the Strategic Plan to determine new and better ways to achieve association goals.</li>
    <li>Advocate for more involvement of diverse members in all aspects of AGA activities; issue an annual report to the governing
        board.
    </li>
    <li>Work with other committees and the AGA Institute Council to effect the mission of the committee; assess the effectiveness
        of such programs annually and report therein to the governing board.</li>
</ul>


<h3>Meetings</h3>

<p>The committee&nbsp;is authorized to hold two face-to-face meetings per year, one in September and one at DDW, and teleconferences
    as needed.</p>

<h3>Members</h3>

<ul>
    <li>Rotonya M. Carr, MD (chair)</li>
    <li>Sandra M. Quezada, MD, MS (chair-elect)</li>
    <li>Aline J. Charabaty Pishvaian, MD</li>
    <li>Chien-Huan Chen, MD, PhD</li>
    <li>LukeJohn Day, MD</li>
    <li>Tolulope Falaiye, MD, MSCI</li>
    <li>Esi Lamouse-Smith, MD, PhD</li>
    <li>Miguel H. Malespin, MD</li>
    <li>Antonio Mendoza Ladd, MD</li>
    <li>Ibironke Oduyebo, MD (trainee member)</li>
</ul>

<p align="right">
    <a href="#top" target="_top">
        <small>Back to Top</small>
    </a>
</p>